TickerFacts.

Carlsmed, Inc. (CARL): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$281.0K
Year ended 2025-12-31
$409.0K
Trailing 12 months to 2026-06-30
2024-12-31: $145.0K2025-12-31: $281.0K$281.0K
2024-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$281.0K+93.8%2026-02-25, From 2025-01-01
2024-12-31$145.0Kn/a2026-02-25, From 2024-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Carlsmed, Inc. (CARL)2025-12-31$281.0K+93.8%
Apyx Medical Corp (APYX)2025-12-31$655.0K+9.3%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$626.0K-15.9%
SANUWAVE Health, Inc. (SNWV)2025-12-31$974.0K+23.6%
SS Innovations International, Inc. (SSII)2025-12-31$1.08M+146.8%
KORU Medical Systems, Inc. (KRMD)2025-12-31$810.5K-8.8%
Interpace Biosciences, Inc. (IDXG)2025-12-31$425.0K+41.7%
Retractable Technologies Inc (RVP)2025-12-31$7.77M+2.6%
Cytosorbents Corp (CTSO)2025-12-31$1.23M-7.6%

Compare CARL, APYX, TLSI, SNWV side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗